Alexion Pharma raises 2014 profit forecast on strong Soliris sales
April 24, 2014 at 08:37 AM EDT
April 24 (Reuters) - Alexion Pharmaceuticals Inc reported stronger-than-expected adjusted net earnings due to robust sales of its sole product on the market, Soliris, and it raised its full-year profit forecast for the second time in less than two months.